3. Learning Objectives

4. Classification of VTE

5. Goals of VTE Treatment

6. Risk of VTE Recurrence

7. Factors That Predict High Risk of Recurrence

8. NOACs VTE Acute Treatment Trials

9. NOACs VTE Extended Treatment Trials

10. Duration of VTE Treatment

11. Extended Therapy for Unprovoked VTE

12. Bleeding Risk Factors

13. Extended Therapy for Provoked VTE

14. When to Stop Extended Therapy

15. Meta-analysis of VTE Studies Safety Outcomes Favor NOACs vs VKA

16. VTE With Persistent Risk Factors

17. Aspirin VTE Extended Treatment

18. VTE Extended Treatment Relative Risk-Benefit of NOAC vs Aspirin

19. Place of Aspirin in VTE Management

20. Vienna Prediction Model

21. NOACs Renal Clearance

22. Hokusai-VTE Trial Dose Adjustment

23. NOACs Bleeding Management

24. Abbreviations

25. References

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)